Skip to content
FDA.report
Public FDA data
NDC
RxNorm
DailyMed
Applications
GUDID
PMA
PMN
MAUDE
Recalls
Search FDA.report
Search
Home
DailyMed
class
47766a6c-066e-4f82-a899-fd0e9c51beb9
GATIFLOXACIN ANHYDROUS Pharmacologic Class Indexing
Class set ID
47766a6c-066e-4f82-a899-fd0e9c51beb9
Version
3
Effective date
20180813
Type
Indexing - Pharmacologic Class
Mapped DailyMed Labels
#
Label, Manufacturer, Effective table
Label
Manufacturer
Effective
SPL version
These highlights do not include all the information needed to use GATIFLOXACIN OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for GATIFLOXACIN OPHTHALMIC SOLUTION. GATIFLOXACIN Ophthalmic Solution, for topical ophthalmic use Initial U.S. Approval: 1999
Leading Pharma, LLC | Caplin Steriles Limited
20251028
2
These highlights do not include all the information needed to use GATIFLOXACIN OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for GATIFLOXACIN OPHTHALMIC SOLUTION. GATIFLOXACIN Ophthalmic Solution, for topical ophthalmic use Initial U.S. Approval: 1999
Caplin Steriles Limited
20250606
1
These highlights do not include all the information needed to use GATIFLOXACIN safely and effectively. See full prescribing information for GATIFLOXACIN. GATIFLOXACIN ophthalmic solution, 0.5% for topical ophthalmic use Initial U.S. Approval: 1999
Akorn | Akorn Operating Company LLC
20220311
7
These highlights do not include all the information needed to use GATIFLOXACIN OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for GATIFLOXACIN OPHTHALMIC SOLUTION. GATIFLOXACIN ophthalmic solution, 0.5% for topical ophthalmic use Initial U.S. Approval: 1999
Sandoz Inc
20210831
14
These highlights do not include all the information needed to use ZYMAXID ® safely and effectively. See full prescribing information for ZYMAXID ® . ZYMAXID ® (gatifloxacin ophthalmic solution ) 0.5% for topical ophthalmic use Initial U.S. Approval: 1999
Allergan, Inc.
20160901
11